These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33797847)

  • 1. Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder.
    Luna-Velez MV; Dijkstra JJ; Heuschkel MA; Smit FP; van de Zande G; Smeets D; Sedelaar JPM; Vermeulen M; Verhaegh GW; Schalken JA
    Mol Oncol; 2021 Jul; 15(7):1882-1900. PubMed ID: 33797847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice.
    Johnson DT; Hooker E; Luong R; Yu EJ; He Y; Gonzalgo ML; Sun Z
    PLoS One; 2016; 11(2):e0148851. PubMed ID: 26862755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of androgen receptor inhibitor and cisplatin, an effective treatment strategy for urothelial carcinoma of the bladder.
    Tyagi A; Chandrasekaran B; Kolluru V; Rai S; Jordan AC; Houda A; Messer J; Ankem M; Damodaran C; Haddad A
    Urol Oncol; 2019 Jul; 37(7):492-502. PubMed ID: 31006613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of AR, 5αR1 and 5αR2 in bladder urothelial carcinoma and relationship to clinicopathological factors.
    Hata S; Ise K; Azmahani A; Konosu-Fukaya S; McNamara KM; Fujishima F; Shimada K; Mitsuzuka K; Arai Y; Sasano H; Nakamura Y
    Life Sci; 2017 Dec; 190():15-20. PubMed ID: 28947209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.
    Sekino Y; Sakamoto N; Ishikawa A; Honma R; Shigematsu Y; Hayashi T; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
    Oncol Rep; 2019 May; 41(5):3111-3118. PubMed ID: 30864720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.
    Boorjian SA; Heemers HV; Frank I; Farmer SA; Schmidt LJ; Sebo TJ; Tindall DJ
    Endocr Relat Cancer; 2009 Mar; 16(1):123-37. PubMed ID: 18845648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
    Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
    Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
    Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
    Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen activates β-catenin signaling in bladder cancer cells.
    Li Y; Zheng Y; Izumi K; Ishiguro H; Ye B; Li F; Miyamoto H
    Endocr Relat Cancer; 2013 Jun; 20(3):293-304. PubMed ID: 23447569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
    Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
    Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer.
    Kauffman EC; Robinson BD; Downes MJ; Powell LG; Lee MM; Scherr DS; Gudas LJ; Mongan NP
    Mol Carcinog; 2011 Dec; 50(12):931-44. PubMed ID: 21400613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth.
    Kawahara T; Ide H; Kashiwagi E; El-Shishtawy KA; Li Y; Reis LO; Zheng Y; Miyamoto H
    Urol Oncol; 2016 Oct; 34(10):432.e15-23. PubMed ID: 27330033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder.
    Erben P; Sikic D; Wirtz RM; Martini T; Weis CA; Breyer J; Otto W; Keck B; Hartmann A; Bolenz C;
    Virchows Arch; 2019 Feb; 474(2):209-217. PubMed ID: 30483954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.
    Brait M; Munari E; LeBron C; Noordhuis MG; Begum S; Michailidi C; Gonzalez-Roibon N; Maldonado L; Sen T; Guerrero-Preston R; Cope L; Parrella P; Fazio VM; Ha PK; Netto GJ; Sidransky D; Hoque MO
    Cell Cycle; 2013 Apr; 12(7):1058-70. PubMed ID: 23435205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.
    Izumi K; Zheng Y; Hsu JW; Chang C; Miyamoto H
    Mol Carcinog; 2013 Feb; 52(2):94-102. PubMed ID: 22086872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen Receptor Transcriptionally Inhibits Programmed Death Ligand-1 Expression and Influences Immune Escape in Bladder Cancer.
    Sun A; Luo Y; Xiao W; Zhu Z; Yan H; Miao C; Zhang W; Bai P; Liu C; Yang D; Shao Z; Song J; Wu Z; Chen B; Xing J; Wang T
    Lab Invest; 2023 Jul; 103(7):100148. PubMed ID: 37059268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals.
    Lin C; Lin W; Yeh S; Li L; Chang C
    Oncotarget; 2015 Dec; 6(40):43081-9. PubMed ID: 26517808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of androgen receptors in urothelial carcinoma of urinary bladder. Is it significant? Experience from coastal India.
    Jindal D; Suresh PK; Sreeram S; Holla R; Kini H; Hb S; Pinto AC
    Arch Ital Urol Androl; 2023 Nov; 95(4):11514. PubMed ID: 38193232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor activation: a prospective therapeutic target for bladder cancer?
    Mizushima T; Tirador KA; Miyamoto H
    Expert Opin Ther Targets; 2017 Mar; 21(3):249-257. PubMed ID: 28064545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer.
    Elahi Najafi MA; Yasui M; Teramoto Y; Tatenuma T; Jiang G; Miyamoto H
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.